Metabolic Complications of HIV and Antiretroviral Therapy

Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

• Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
• Section Editor: Daniel R. Kuritzkes, MD
• Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD; Kathleen E. Squires, MD
• Last Reviewed: 7/23/15 (What's New)

Summary

• Traditional risk factors for dyslipidemia remain relevant to HIV-infected patients
  • These include older age, male sex, family history, poor diet, increased BMI, and sedentary lifestyle
• All HIV-infected patients should have fasting lipids evaluated at entry to care and before ART initiation (C)[Aberg 2014]
PIs and Dyslipidemia
NRTIs and Dyslipidemia
NNRTIs and Dyslipidemia
Integrase Inhibitors, Maraviroc, and Dyslipidemia